Melanocortin therapies to resolve fibroblast-mediated diseases.

Khodeneva, Natalya; Sugimoto, Michelle A; Davan-Wetton, Camilla S A; Montero-Melendez, Trinidad

Khodeneva, Natalya; Sugimoto, Michelle A; Davan-Wetton, Camilla S A; Montero-Melendez, Trinidad.

Afiliação

Khodeneva N; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Sugimoto MA; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Davan-Wetton CSA; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Montero-Melendez T; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Front Immunol ; 13: 1084394, 2022.

Article em En | MEDLINE | ID: mdl-36793548

Assuntos

Artrite Reumatoide; Melanocortinas; Humanos; Melanocortinas/metabolismo; Melanocortinas/uso terapêutico; Fibroblastos/metabolismo; Miofibroblastos/metabolismo; Colágeno/metabolismo; Artrite Reumatoide/metabolismo

Palavras-chave

drug development; fibroblasts; fibrosis; melanocortin; resolution of inflammation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Melanocortinas Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google